*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Rare Case Report on Ewing’s Sarcoma and Its Clinical Management: A Role of Clinical Pharmacist’s Intervention for Achieving Better Therapeutic Outcome in Cancer Care

Author: RAJESH HADIA, KUSHAL GOHEL, SUNIL KARDANI, DHAVAL JOSHI
Abstract: Ewing’s sarcoma is a highly malignant tumor of bone that occurs in children’s, adolescents, and young adults. Ewing’s sarcoma has an extremely high fatality rate. The main objective of this study was to spread awareness to the healthcare professionals regarding rare clinical condition, drug related problems with preventive measures and clinical management of rare disease. The main clinical pharmacist intervention made after reviewing the patient case profile clinical pharmacist has suggested a preventive measures and clinical management of drug related problems to medical oncology for better therapeutic outcome in cancer care, so patient health related quality of life will be improve. The following drug related problems and clinical managements are mentioned in below. Clinical pharmacist has monitored and reported ifosfamide induced hematuria and suggested to prescribe Injection Mesna 200 mg at 0-4-8 hourly for prevention of ifosfamide related bladder toxicity. Clinical pharmacist after reviewing of all previous CBC results and suggested to medical oncologist to prescribe Injection Pegfilgrastin 300 mcg SC (1 day) instead of Injection Filgrastine 300 mcg SC (4 days). Pegfilgrastin has a better efficacy, potency and reduced the prolongation of hospital related cost because of reduction of frequency of treatment drug. We have described a unique case of Ewing’s sarcoma and its clinical management so many healthcare professional will get critical information related to rare type of cases. In this case role of clinical Pharmacist's interventions is most important for achieving better therapeutic outcomes and patient health related quality of life and cost in cancer care as well as reduced the burden of the medical oncologist.
Keyword: CD 99, Ewing's sarcoma, EWS gene.
DOI: https://doi.org/10.31838/ijpr/2020.SP1.095
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free